Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04270227
Other study ID # Body awareness_Exercise
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2020
Est. completion date April 13, 2020

Study information

Verified date April 2020
Source Istanbul Medipol University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Healthy volunteers between the ages of 18-25 who will not have any problems preventing physical activity will be included among the university students. The criteria for not being included in the study were determined as being diagnosed with any disease that impedes physical activity and not wanting to participate in the study. Participation in the investigator's study is completely voluntary. Individuals who do not wish to participate in the study will be excluded. Cases with missing survey and demographic information will be excluded from the study. The planned study is a cross-sectional study.


Recruitment information / eligibility

Status Completed
Enrollment 116
Est. completion date April 13, 2020
Est. primary completion date April 13, 2020
Accepts healthy volunteers
Gender All
Age group 18 Years to 25 Years
Eligibility Inclusion Criteria:

- Not having any problems preventing physical activity

- No identified chronic disease

- Being between the ages of 18-25

Exclusion Criteria:

-Not want to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey study
The questionnaire including Exercise Benefits / Barriers Scale, IPAQ (International Physical Activity Survey), The Bady Awareness questionnaire and demographic information will be filled in one time by face-to-face interview method.

Locations

Country Name City State
Turkey Esra Pehli?van Istanbul Üsküdar

Sponsors (1)

Lead Sponsor Collaborator
Istanbul Medipol University Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body awareness scale (Body awareness questionnaire-Turkish) It is a questionnaire consisting of four subgroups (changes in the body process, sleep-wake cycle, prediction at the onset of the disease, prediction of body responses) and a total of 18 expressions aimed at determining the normal or abnormal sensitivity level of the body composition. The participant is asked to score between one and seven numbers for each statement. In the survey, the ratings are made as total points. The high score shows that body sensitivity is better. 15 minutes
Secondary Exercise Benefits/Barriers Scale It is a 43-item questionnaire using the 4-item Likert scale. The score varies between 43 and 172. High scores on the benefits scale show the perceived benefits of physical activity, while high scores on the barrier scale show that perceived barriers to physical activity are low. 15 minutes
Secondary International Physical Activity Questionnaire Short Form Physical activity levels of the participants according to the total physical activity score; It was classified as physically inactive (3000MET-min / hf) and low physical activity level (600-3000 MET-min / hf) with sufficient physical activity level (> 3000MET-min / hf). 15 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1